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 ABSTRACT 
 
 
 
OBJECTIVE: The objective of this selective EBM review is to determine whether or not 
stimulating acupoints on the skin in addition to standard medication is more effective for the 
improvement of breathlessness in ambulatory patients with COPD over the age of 60 than 
standard medication alone. 
 
STUDY DESIGN: Review of three randomized controlled trials published in 2008, 2010, and 
2012; selection was based on their relevance to the clinical question and if they contained patient 
oriented outcomes. 
 
DATA SOURCES: Three peer-reviewed randomized controlled trials comparing the addition of 
acupuncture/Acu-Tens to standard treatment and standard treatment alone were found on 
PubMed. 
 
OUTCOME(S) MEASURED: Each trial assessed the effect of skin stimulation by acupuncture 
and/or Acu-Tens on decreasing the amount of breathlessness that patients with COPD experience 
by obtaining lung function or utilizing a 6-minute walk test after the skin stimulation and 
evaluating the findings from a patient’s perspective via Visual Analogue Scale (VAS) or a 10-
point Borg category ratio scale.  
 
RESULTS: Two studies demonstrated a statistically significant improvement in breathlessness 
achieved with the addition of acupuncture/Acu-Tens to standard COPD therapy versus standard 
therapy alone. The third study failed to show improvement in breathlessness; it only 
demonstrated an improvement in walk distance. 
 
CONCLUSIONS: Based on the three trials, the use of acupuncture/Acu-Tens is inconclusive 
when determining improved breathlessness in patients over the age of 60 with COPD.  
 
KEY WORDS: acupuncture, COPD, pulmonary disease, breathlessness 
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INTRODUCTION 
 Chronic obstructive pulmonary disease (COPD) is “a common preventable and treatable 
disease, characterized by persistent airflow limitation that is usually progressive and associated 
with and enhanced chronic inflammatory response in the airways and the lung to noxious 
particles or gases1.” Shortness of breath is one of the most common symptoms in patients with 
this disease. Currently, COPD is the third leading cause of death in America2, and it affects 24 
million Americans today3. The breathlessness that results from COPD can have a significant 
impact on patients in their everyday lives. Even simple tasks can become difficult to perform.  
 The cost to treat COPD is incredulous, with an estimated $37 billion spent annually on 
the care of patients in the United States4 alone. Reports have shown that there are 15 million 
office visits each year for patients with COPD5.  
 COPD is a well-studied disease and health care providers are aware of its cause; alveoli 
in the lungs are destroyed due to an immune or environmental insult, which hinders oxygen 
exchange, ultimately leading to airflow obstruction. Symptoms such as dyspnea, chronic cough, 
and chronic sputum production result. Tobacco use is the chief cause of the disease. However, 
patients exposed to second-hand smoke and fumes are also at risk. Alpha-1 antitrypsin deficiency 
is a hereditary risk factor.  
 Smoking cessation is the most important intervention for the improvement of COPD1. 
However, there are a variety of drug classes that are used to treat patients with COPD as well. 
Standard therapy consists of utilizing a drug class alone or in combination. Pharmacologic 
therapeutic options consist of bronchodilators, such as anti-cholinergics and beta2-agonists, 
methylxanthines, inhaled corticosteroids, and phosphodiesterase-4 inhibitors. Non-therapeutic 
options include pulmonary rehabilitation, oxygen therapy, ventilatory support with non-invasive 
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ventilation, lung volume reduction surgery, bronchoscopic lung volume reductions, lung 
transplantation, and bullectomy. According to the Global Initiative for Chronic Obstructive Lung 
Disease, “The choice within each class depends on the availability and cost of medication and 
the patient’s response. Each treatment regimen needs to be patient-specific as the relationship 
between severity of symptoms, airflow limitation, and severity of exacerbations will differ 
between patients1.”  
 The current treatment offered to patients with COPD targets anatomic and physiologic 
abnormalities that are reversed with medications or invasive surgical procedures. If health care 
providers further study the mechanisms associated with COPD, they can begin to acknowledge 
that the peripheral nervous system, specifically the autonomic nervous system, has not been 
explored to great lengths. This nervous system plays a role in the symptomatic response of 
patients with COPD, such as dyspnea and cough. No direct treatment options available are being 
studied to address this physiologic mechanism. In the second edition of Harrison’s Pulmonary 
and Critical Care Medicine, “A discrepancy or mismatch between the feed-forward message to 
the ventilatory muscles and the feedback from receptors that monitor the response of the 
ventilatory pump increases the intensity of dyspnea6.” Also, for patients experiencing anxiety 
pertaining to the hyperventilation that can occur from COPD, breathlessness can worsen because 
“in patients with expiratory flow limitation, the increased respiratory rate that accompanies acute 
anxiety leads to hyperinflation, increased work and effort of breathing, and a sense of an 
unsatisfying breath6.” For this reason, acupuncture can be a therapeutic option stimulating the 
nervous system in such a way that relieves the breathlessness stemming from COPD. With 
acupuncture, acupuncture points are identified and designated as areas of electrical sensitivity. 
Inserting needles at these locations stimulates numerous sensory receptors which ultimately 
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activate the nerves that transmit impulses to the hypothalamic-pituitary system at the base of the 
brain. This area of the brain is responsible for the release of endorphins, which decrease the 
stress response.7 Acupuncture also “acts by blocking the action of the parasympathetic nervous 
system, and to enhance the action of the sympathetic nervous system. These two systems are 
responsible for constricting and relaxing bronchial smooth muscle.8” This is a similar to the 
mechanism of β2-adrenergic receptor agonists, or bronchodilators. Transcutaneous electrical 
nerve stimulation or “TENS is a method of electrical stimulation which primarily aims to provide 
a degree of symptomatic pain relief by exciting sensory nerves and thereby stimulating either the 
pain gate mechanism and/or the opioid system.9” When a patient is experiencing breathlessness, 
this puts stress on the body. Consequently, acupoint stimulation decreases that stress response 
providing relaxation and decreasing the effort it takes to breathe. Furthermore, acupuncture and 
TENS are other modalities that are not only cost-effective, but can also be applied before 
resorting to invasive procedures when COPD becomes uncontrolled or unresponsive to 
pharmacologic treatment.  
OBJECTIVE 
 The objective of this selective EBM review is to determine whether or not stimulating 
acupoints on the skin in addition to standard medication is more effective for the improvement of 
breathlessness in ambulatory patients with COPD over the age of 60 than standard medication 
alone. 
METHODS 
 Three peer-reviewed randomized controlled trials were used for this review. Each study’s 
population was comprised of ambulatory patients with COPD who are 60 years of age or older 
and are currently on standard medical regimens for their condition. The Inclusion Criteria used 
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for the selection of studies chosen to answer the EBM question included patients who had not 
tried acupuncture treatments before, were currently compliant with a standard treatment regimen, 
were able to walk unassisted, and patients who were outpatients. For this review, a comparison 
was made between patients with COPD on a standard treatment regimen and who were receiving 
acupuncture and patients with COPD who were solely on a standard treatment regimen. 
Acupuncture was the intervention used. The specific form of acupuncture varied amongst the 
studies, but the same method of stimulating precise acupoints via external stimuli to activate the 
areas controlling respiration was administered. After the acupoints were stimulated, each trial 
monitored its patients with either the Visual Analogue Scale or the 10-point Borg Category Ratio 
Scale as a way to assess how the patients felt before and after the event. Along with this 
subjective way of measuring the effectiveness of acupuncture, two of the studies carried out 6-
minute walk tests to objectively measure how patients’ walk distance improved after the 
treatment.  
 Key words used in the search for this topic included acupuncture, COPD, pulmonary 
disease, and breathlessness. Each article was written in English and published between 2008 and 
2012. The chosen articles were found through the PubMed database by the author, and selected 
based on their relevance to the clinical question and if they contained patient-oriented outcomes. 
Summary of statistics were reported by using p-values and confidence intervals.  
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Table 1: Demographics & Characteristics of Included Studies 
Study Type #Pts Age (yrs) Inclusion 
Criteria 
Exclusion 
Criteria 
W/D Interventions 
Lau, 2008 
(1) 
RCT 46 Mean age 
of 75 y/o 
Pts with stage I 
or II COPD 
according to 
GOLD 
classification, 
able to 
communicate, 
independent in 
mobility, and 
with no previous 
experience with 
Acu-
Tens/acupuncture 
Pts with co-
existing 
ischemic heart 
disease, cardiac 
pacemaker, 
diabetes 
mellitus, 
neurological 
deficit, or poor 
cognitive 
function, 
previously 
received Acu-
Tens, and had 
acute 
exacerbations 
within 1 month 
of study 
0 Experimental 
group 
received 45 
minutes of 
Acu-TENS 
over 
acupoints, 
while control 
group 
received 
placebo-
TENS with 
identical 
electrode 
placement 
but no 
electrical 
output  
Ngai, 
2010 (2) 
RCT 28 > 67 y/o Patients with 
diagnosis of 
COPD based on 
the GOLD 
guideline and 
attending regular 
follow-up at the 
respiratory clinic  
Pts unable to 
perform 
spirometry 
testing, 
confused/ 
incommunicable, 
allergic to 
aqueous gel, or 
suffering from 
URI or COPD 
exacerbation in 
the past 6 weeks 
and/or having 
musculoskeletal 
disorders  
0 4-weeks of 
45-min, 5-
days/week, 
of  Acu-
TENS vs 
placebo-
TENS vs 
Sham-Tens 
Suzuki, 
2012 (3) 
RCT 68 <75 to > 
or = to 75 
y/o 
Pts with stage II-
IV COPD, 
clinically stable, 
no changes in 
medication 
within past 3 
months, and no 
signs of edema; 
stage II or higher 
dyspnea, able to 
walk unassisted, 
no pulmonary 
rehabilitation in 
the previous 6 
mo., outpatients 
only. 
Pts presenting 
with evidence of 
CV or collagen 
disease, renal 
failure, thyroid 
dysfunction, 
hepatic function 
disorder, cancer, 
and  mental 
disorders 
6 Traditional 
acupuncture 
needling vs. 
placebo 
needling 1 
time per 
week for 12 
weeks. 
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OUTCOMES MEASURED 
 The outcome measured was a decrease in COPD-associated breathlessness using the 
Visual Analogue Scale (VAS) and the 10-point Borg Category Ratio Scale. Patients rated their 
breathlessness on one of these scales before and after acupuncture was performed. The VAS 
measured patients’ dyspnea in a range of 0-mm to 100-mm where 0-mm signified “no shortness 
of breath” and 100-mm signified “shortness of breath as bad as can be.” The 10-point Borg 
Category Ratio Scale measured how patients felt with 0 signifying “breathing very well, barely 
breathless” and 10 signifying “severely breathless.” Furthermore, two of the studies utilized a 6-
minute walk test (6MWT) in conjunction with the scales. Effectiveness of acupuncture was 
analyzed in one of the studies by measuring the distance a patient could walk for 6 minutes 
before and after the treatment.  
 In the randomized, placebo-controlled, pre-test and post-test study by Lau et al., dyspnea 
was measured using the VAS before and after a patient’s Acu-TENS treatment, and “all 
measurements were performed in the sitting position and the best of 3 trials was recorded10.” 
Improvement in symptoms was based on a decrease in the pre-test/post-test VAS score and a 
mean change from baseline as compared to the control group. 
 In the randomized controlled trial by Ngai et al., dyspnea was measured on the VAS 
before and after a patient’s Acu-TENS treatment. This study also measured the outcomes by 
performing a 6MWT, which had patients walk down a 100-foot hallway for 6 minutes and their 
distance walked was assessed before and after they received an Acu-TENS treatment. 
Improvement in breathlessness was measured based on a decrease in the pre-test/post-test VAS 
score and how much further a patient could walk after Acu-TENS. 
 Sbat, Acupuncture For COPD Patients  7 
 In the randomized, placebo-controlled, single blind study by Suzuki et al., dyspnea was 
measured by having patients rate how they felt before and after an acupuncture treatment on the 
10-point Borg Category Ratio Scale. A 6MWT was also performed before and after an 
acupuncture treatment. Distance was not measured for the 6MWT, but the 10-point Borg 
Category Ratio Scale was used to assess the patient-oriented outcome after the walk. 
RESULTS 
In the Lau et al. study, 46 patients were chosen based on being diagnosed with Stage I or 
II COPD, ability to communicate, independence in mobility, and without previous experience 
with Acu-TENS10. “Eligible participants were then randomly assigned to either the experimental 
(Acu-TENS) or control (placebo-TENS) group10.” Each group went through 45 minutes of 
acupuncture, with the control group receiving a placebo version of the technique. In the 
experimental group, the Acu-TENS electrodes were placed on the EX-B1 acupoint bilaterally, 
“lateral to the spinous process of the 7th cervical vertebra10.” All patients were asked to fill out 
the VAS before and after the treatment. The pre-test to post-test score using the VAS was 81-mm 
to 67-mm respectively, signifying a large effect on decreasing breathlessness. Also, the change in 
mean from baseline was a 13% decrease in the breathlessness score. The experimental group’s 
“shortness of breath had decreased by 11-mm on the VAS (95% CI -14 to -8) more than the 
control group.10” 
Table 2: VAS Scores Before and After Treatment in Lau Study 
Pre-test Score: Placebo-TENS Post-test Score: Placebo-TENS 
77-mm 74-mm 
Pre-test Score: Acu-TENS Post-test Score: Acu-TENS 
81-mm 67-mm 
 
In the Ngai et al. study, 28 patients were chosen who had a diagnosis of COPD, and were 
attending regular follow-up at the respiratory clinic11. The patients were randomly placed in an 
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experimental Acu-TENS group and a controlled Placebo-TENS group. The treatment was 
administered 5 days a week for 4 weeks. As in the Lau et al. study, the EX-B1 acupoint was 
stimulated. For the results of the 6MWT seen in Table 3, the Acu-TENS group had a significant 
increase in patient walk distance (p = 0.045) when compared to the Placebo-TENS group11. 
Dyspnea was measured on the VAS with a pre-treatment score of 18.0-mm and a post-treatment 
score of 18.0-mm. 
Table 3: 6MWT Pre-test and Post-test Distances in Ngai Study 
Pre-Test Distance: Placebo-TENS Post-test Distance: Placebo-TENS 
325.7 meters 333.8 meters 
Pre-Test Distance: Acu-TENS Post-test Distance: Acu-TENS 
305.8 meters 329.5 meters 
 
Table 4: VAS Scores Before and After Treatment in Ngai Study 
Pre-test Score: Placebo-TENS Post-Test Score: Placebo-TENS 
24.5-mm 24.5-mm 
Post-test Score: Acu-TENS Post-test Score: Acu-TENS 
18.0-mm 18.0-mm 
 
In the Suzuki et al. study, 68 patients were chosen according to having the diagnosis of 
stage II-IV COPD, no changes in medication within the past 3 months, no signs of edema, the 
ability to walk unassisted, an outpatient status, and no pulmonary rehabilitation in the previous 6 
months12. Acupuncture treatment with stimulation of acupoints close to the respiratory accessory 
muscles was given 1 time per week for 12 weeks to the real acupuncture group (RAG). The 
placebo acupuncture group (PAG) received placebo needling at the same acupoints for the same 
amount of time as the RAG. On the 10-point Borg Category Ratio Scale, patients were asked to 
document their breathlessness before treatment as a baseline, and then after the 12 weeks were 
over. “The difference between baseline and final volumes was compared using analysis of 
covariance with baseline values and age as covariates and treatment group as the factor of 
interest12.” After the 12-week treatment period, the Borg scale score for the RAG decreased from 
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5.5 to 1.9. No improvement was seen in the Borg scale score for the PAG (4.2 to 4.6). The 
difference in the scores between the RAG and the PAG “was statistically significant…; mean 
difference by analysis of covariance, -3.58; (95% CI, -4.27 to -2.90)12.”  
Table 5: 10-Point Borg Category Ratio Scale Scores 
Borg Scale Score Baseline 12 weeks Post Treatment 
PAG 4.2 4.6 
RAG 5.5 1.9 
 
DISCUSSION 
 The benefit of acupuncture therapy on decreasing breathlessness in patients with COPD 
is a subject matter that is not fully understood. The findings in this review provide evidence that 
acupuncture does have a slight positive impact on breathlessness when the correct acupoints are 
stimulated. However, this impact is not effective enough to rid these patients of breathlessness to 
a point of total relief.  
 Lau et al. and Suzuki et al. both proved that the effect of acupuncture on breathlessness 
was statistically significant. This can be seen in the patient reports found in the pre-test and post-
test VAS and 10-point Borg Category Ratio Scale in concordance with a 6MWT from each study 
respectively. In contrast, Ngai et al. did not demonstrate any improvement in breathlessness; the 
study only revealed an increase in walk distance.  
 There were, however, limitations to the randomized controlled trials examined in this 
review. In all three studies, the sample sizes, which were mentioned earlier in this review under 
the RESULTS section, were not large enough to truly see the effects of acupuncture on a vast 
group of people. In the Ngai et al. and Suzuki et al. studies, no follow-up was conducted, which 
did not enable the long-term effects of the acupuncture to be observed. In Suzuki et al., the 
acupuncture therapists were not blinded. In the Lau et al. study, patients did not have their 
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bronchodilators with them during the trial, so normal resting levels of breathlessness may be 
altered. Also, the study was done in one, single session.  
 Even though acupuncture is a form of Chinese traditional medicine, it is more widely 
used in the United States today for many conditions including, but not limited to migraines, 
chronic pain, osteoarthritis, addiction, insomnia, constipation, and so on13. Acupuncture therapy 
is a safe and cost-effective choice of treatment and “the FDA approved acupuncture needles for 
use by licensed practitioners in 199614.” Because of its rise in popularity, acupuncture is more 
readily available for patients who are willing to utilize it as adjunctive therapy to their current 
treatment regimen.  
CONCLUSION 
 In conclusion, the evidence obtained was inconclusive and conflicting to support the 
subject matter of acupuncture being utilized to decrease breathlessness in ambulatory patients 
with COPD who are 60 years of age and older. Two studies, Lau et al. and Suzuki et al. proved 
the effectiveness of acupuncture pre- and post- therapy. However, Ngai et al. was inconsistent 
and did not show any significant improvement in regards to breathlessness. All of the studies 
demonstrated affirmative results in specific areas, but these results were not significant for the 
topic of interest and were, therefore, inconclusive.  
 Because the evidence gathered for this review is inconclusive, more research is needed to 
verify whether or not acupuncture is truly beneficial and should be included in the treatment of 
patients with COPD. Acquiring larger sample sizes all with patients in the same stage of COPD, 
extending the time-frame of each study to at least 6 months, planning for a longer follow-up 
protocol, stimulating the same acupoints in all trials, and every study performed should evaluate 
patients consistently with Visual Analogue Scale, a 6MWT, and full pulmonary function tests to 
 Sbat, Acupuncture For COPD Patients  11 
see the true effects of acupuncture overtime are all essential to improving the outcomes of this 
non-pharmaceutical treatment in patients with COPD.  
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